Clinical Trial Update: Xolair in Patients With Chronic Sinusitis [Phase 4]

View source ↗

Summary

Phase 4 trial update for Xolair (omalizumab) in chronic sinusitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sinusitis

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: University of Chicago | Conditions: Sinusitis | Phase 4 | Status: COMPLETED